Additionally, TLR4 and ABCA1 showed significant upregulation specifically in CD16+ monocytes of COVID-19 patients (Figure 9E), suggesting their potential involvement in the immune response during COVID-19. The gene discussed is TLR4; the disease is COVID-19.